Glicina, mínimo 99%, para síntesis, 250 g, envase plástico.

8-BOC-2-OXO-8-AZABICYCLO[3.2.1]OCTANE, 95.0%, 1g

t-Butyl trifluoroacetate, 98%, 250mg

2-Bromo-5-chloro-4-fluoronitrobenzene, 95.0%, 10g

Bromoacetaldehyde dimethyl acetal, 97.0%, 1kg

Benzyl 4-(4-((tert-butoxycarbonyl)amino)cyclohexyl)piperazine-1-carboxylate, 95+%, 1g

4-Bromo-2,6-dimethylaniline>98.0%(GC)(T)100g

(2E)-1-(2,5-dichlorophenyl)-3-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 10g

4-(2-Amino-ethyl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester, 5g

Methyl 2,2,3,3,3-Pentafluoropropyl Ether>98.0%(GC)1g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 750m2/g)5g

2-Bromo-3-chloro-6-hydroxybenzaldehyde, 250mg

4-AMINO-2-CHLORO-5-IODOBENZONITRILE, 95.0%, 250mg